EOX regimen

Jump to navigation Jump to search

WikiDoc Resources for EOX regimen

Articles

Most recent articles on EOX regimen

Most cited articles on EOX regimen

Review articles on EOX regimen

Articles on EOX regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on EOX regimen

Images of EOX regimen

Photos of EOX regimen

Podcasts & MP3s on EOX regimen

Videos on EOX regimen

Evidence Based Medicine

Cochrane Collaboration on EOX regimen

Bandolier on EOX regimen

TRIP on EOX regimen

Clinical Trials

Ongoing Trials on EOX regimen at Clinical Trials.gov

Trial results on EOX regimen

Clinical Trials on EOX regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on EOX regimen

NICE Guidance on EOX regimen

NHS PRODIGY Guidance

FDA on EOX regimen

CDC on EOX regimen

Books

Books on EOX regimen

News

EOX regimen in the news

Be alerted to news on EOX regimen

News trends on EOX regimen

Commentary

Blogs on EOX regimen

Definitions

Definitions of EOX regimen

Patient Resources / Community

Patient resources on EOX regimen

Discussion groups on EOX regimen

Patient Handouts on EOX regimen

Directions to Hospitals Treating EOX regimen

Risk calculators and risk factors for EOX regimen

Healthcare Provider Resources

Symptoms of EOX regimen

Causes & Risk Factors for EOX regimen

Diagnostic studies for EOX regimen

Treatment of EOX regimen

Continuing Medical Education (CME)

CME Programs on EOX regimen

International

EOX regimen en Espanol

EOX regimen en Francais

Business

EOX regimen in the Marketplace

Patents on EOX regimen

Experimental / Informatics

List of terms related to EOX regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

EOX regimen refers to a regimen consisting of epirubicin, oxaliplatin, capecitabine (xeloda) used to treat advanced oesophagogastric cancer.[1]

Regimen

EEpirubicin

OOxaliplatin

XCapecitabine (xeloda)

Indications


References

  1. 1.0 1.1 Sumpter K, Harper-Wynne C, Cunningham D, Rao S, Tebbutt N, Norman AR; et al. (2005). "Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF". Br J Cancer. 92 (11): 1976–83. doi:10.1038/sj.bjc.6602572. PMC 2361798. PMID 15928658.